Pharmacokinetics of plasma‐derived C 1‐esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study-Reference-Cited by-同舟云学术

Pharmacokinetics of plasma‐derived C 1‐esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study

Published:2013-11-24 Issue:6 Volume:54 Page:1552-1561
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Martinez‐Saguer Inmaculada¹,Cicardi Marco²,Suffritti Chiara²,Rusicke Eva³,Aygören‐Pürsün Emel³,Stoll Hildegard⁴,Rossmanith Tanja⁵,Feussner Annette⁶,Kalina Uwe⁶,Kreuz Wolfhart¹

Affiliation:

1. Hemophilia Center Rhine Main GmbH Mörfelden‐Walldorf Germany

2. Department of Clinical Science “Luigi Sacco,” University of Milan Milan Italy

3. Department of Pediatric Hematology, Oncology, Hemostaseology and Cardiology University Hospital Frankfurt Frankfurt am Main Germany

4. Technical Solutions Center Siemens Healthcare Diagnostics GmbH Eschborn Germany

5. Clinical Trial Center Rhine‐Main (KSRM) University Hospital Frankfurt Frankfurt am Main Germany

6. CSL Behring GmbH Marburg Germany

Funder

CSL Behring Foundation for Research and Advancement of Patient Health

Publisher

Wiley

Subject